AHEAD Intelligence Limited
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
AHEAD utilizes proprietary AI technology to develop innovative flow cytometry analysis tools, providing automatic, rapid, and standardized analysis for the international medical testing field, addressing the challenge of professional staffing shortages.
P
P
Founded Year
2021
Unified Business No.
90703305
Status
Active
Number of Employees
0
Total Paid-in
Capital
0 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
AHEAD Medicine is transforming healthcare through innovative AI technology. Our flagship Cyto-copilot platform employ AI to streamline the flow cytometry data analysis workflow. Cyto-copilot empowers healthcare providers to deliver faster, more consistent, standardized and scalable results for disease diagnosis, patient monitoring, and cell therapy quality control.
